Gene Polymorphism of Taste Receptors and Circulating Endocannabinoids in Normal Weight and Obese Subjects

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02729584

Enrollment

110

Registered

2016-04-06

Start date

2013-04-30

Completion date

2015-09-30

Last updated

2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional Physiological Phenomena

Brief summary

The study aims at evaluating in normal weight and obese subjects those factors such as taste sensitivity and circulating endocannabinoids in influencing dietary choice and thereby lipid and energy metabolism in order to design personalized nutritional strategies.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Body Mass Index (BMI), range for normal weight subjects 17.5-24.95, for obese subjects 29.6-52.20 * No intake of nutritional supplements for at least six months before the trial

Exclusion criteria

* major diseases (diabetes, kidney disease, etc.), * pregnancy or lactation; * food allergies; * the use of medications that interfere with taste or smell (e.g., steroids, antihistamines, certain antidepressants).

Design outcomes

Primary

Measure	Time frame
Endocannabinoid plasma levels	1 year

Outcome results